MedPath

PROPYLTHIOURACIL

Propylthiouracil Tablets, USP

Approved
Approval ID

ae65e8b0-91b2-4a3f-8e1a-279e47eee951

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 15, 2023

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

PROPYLTHIOURACIL

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72162-2072
Application NumberANDA080154
Product Classification
M
Marketing Category
C73584
G
Generic Name
PROPYLTHIOURACIL
Product Specifications
Route of AdministrationORAL
Effective DateAugust 15, 2023
FDA Product Classification

INGREDIENTS (6)

PROPYLTHIOURACILActive
Quantity: 50 mg in 1 1
Code: 721M9407IY
Classification: ACTIB
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE AInactive
Code: H8AV0SQX4D
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PROPYLTHIOURACIL - FDA Drug Approval Details